Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1035

1.

2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.

Frezza AM, Lee ATJ, Nizri E, Sbaraglia M, Jones RL, Gronchi A, Dei Tos AP, Casali PG.

ESMO Open. 2018 Jun 28;3(4):e000390. doi: 10.1136/esmoopen-2018-000390. eCollection 2018. Review.

2.

Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation.

Hallin M, Miki Y, Hayes AJ, Jones RL, Fisher C, Thway K.

Rare Tumors. 2018 Jun 20;10:2036361318782626. doi: 10.1177/2036361318782626. eCollection 2018.

3.

Pancreaticoduodenectomy for the Management of Pancreatic or Duodenal Metastases from Primary Sarcoma.

Huddy JR, Sodergren MH, Deguara J, Thway K, Jones RL, Mudan SS.

Anticancer Res. 2018 Jul;38(7):4041-4046. doi: 10.21873/anticanres.12693.

PMID:
29970529
4.

Measuring Aerosol Phase Changes and Hygroscopicity with a Microresonator Mass Sensor.

Zielinski AT, Gallimore PJ, Griffiths PT, Jones RL, Seshia AA, Kalberer M.

Anal Chem. 2018 Jul 3. doi: 10.1021/acs.analchem.8b00114. [Epub ahead of print]

PMID:
29969232
5.

Assessing the stability of Cd, Mn, Pb, Se, and total Hg in whole human blood by ICP-DRC-MS as a function of temperature and time.

Tevis DS, Jarrett JM, Jones DR, Cheng PY, Franklin M, Mullinex N, Caldwell KL, Jones RL.

Clin Chim Acta. 2018 Jun 9;485:1-6. doi: 10.1016/j.cca.2018.05.043. [Epub ahead of print]

PMID:
29894782
6.

The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk.

Gronchi A, Jones RL.

JAMA Oncol. 2018 Jun 7. doi: 10.1001/jamaoncol.2018.1392. [Epub ahead of print] No abstract available.

PMID:
29879269
7.

Viscoplastic fracture transition of a biopolymer gel.

Frieberg BR, Garatsa RS, Jones RL, Bachert JO, Crawshaw B, Liu XM, Chan EP.

Soft Matter. 2018 Jun 13;14(23):4696-4701. doi: 10.1039/c8sm00722e.

PMID:
29856452
8.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkovski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 May 28. doi: 10.1093/annonc/mdy095. [Epub ahead of print] No abstract available.

PMID:
29846513
9.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkovski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 May 28. doi: 10.1093/annonc/mdy096. [Epub ahead of print] No abstract available.

PMID:
29846498
10.

Effects of micronutrients on placental function: evidence from clinical studies to animal models.

Baker BC, Hayes D, Jones RL.

Reproduction. 2018 May 29. pii: REP-18-0130. doi: 10.1530/REP-18-0130. [Epub ahead of print]

PMID:
29844225
11.

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.

Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick JL, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne SL, Sbaraglia M, Thway K, Wagrodzki M, Wang WL, Yoshida A, Mariani L, Kawai A, Stacchiotti S.

JAMA Oncol. 2018 Apr 12. doi: 10.1001/jamaoncol.2018.0219. [Epub ahead of print]

PMID:
29800950
12.

Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response.

Libertini M, Mitra I, van der Graaf WTA, Miah AB, Judson I, Jones RL, Thomas K, Moskovic E, Szucs Z, Benson C, Messiou C.

Clin Sarcoma Res. 2018 May 14;8:13. doi: 10.1186/s13569-018-0100-3. eCollection 2018.

13.

Perspectives on the evolving state of the art management of gastrointestinal stromal tumours.

Szucs Z, Jones RL.

Transl Gastroenterol Hepatol. 2018 Apr 26;3:21. doi: 10.21037/tgh.2018.04.02. eCollection 2018. Review.

14.

Quality of life and patients' expectations in soft tissue sarcoma.

Jones RL, Cesne AL.

Future Oncol. 2018 May;14(10s):51-62. doi: 10.2217/fon-2018-0077.

PMID:
29768053
15.

Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling.

Reichardt P, Tabone MD, Mora J, Morland B, Jones RL.

Future Oncol. 2018 May 11. doi: 10.2217/fon-2018-0210. [Epub ahead of print]

16.

Cell free hemoglobin in the fetoplacental circulation: a novel cause of fetal growth restriction?

Brook A, Hoaksey A, Gurung R, Yoong EEC, Sneyd R, Baynes GC, Bischof H, Jones S, Higgins LE, Jones C, Greenwood SL, Jones RL, Gram M, Lang I, Desoye G, Myers J, Schneider H, Hansson SR, Crocker IP, Brownbill P.

FASEB J. 2018 May 3:fj201800264R. doi: 10.1096/fj.201800264R. [Epub ahead of print]

PMID:
29723064
17.

The current landscape of early drug development for patients with sarcoma in the immunotherapy era.

Sebio A, Wilky BA, Keedy VL, Jones RL.

Future Oncol. 2018 May;14(12):1197-1211. doi: 10.2217/fon-2017-0565. Epub 2018 Apr 27.

PMID:
29699407
18.

Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials.

Younger E, Litière S, Le Cesne A, Mir O, Gelderblom H, Italiano A, Marreaud S, Jones RL, Gronchi A, van der Graaf WTA.

Oncologist. 2018 Apr 12. pii: theoncologist.2017-0598. doi: 10.1634/theoncologist.2017-0598. [Epub ahead of print]

PMID:
29650688
19.

Endometrial Stromal Sarcoma With Hyalinizing Giant Rosettes, Mimicking Low-Grade Fibromyxoid Sarcoma.

Kolson Kokohaare E, Strauss DC, Jones RL, Thway K.

Int J Surg Pathol. 2018 Apr 1:1066896918767547. doi: 10.1177/1066896918767547. [Epub ahead of print]

PMID:
29623744
20.

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.

Palmerini E, Jones RL, Setola E, Picci P, Marchesi E, Luksch R, Grignani G, Cesari M, Longhi A, Abate ME, Paioli A, Szucs Z, D'ambrosio L, Scotlandi K, Fagioli F, Asaftei S, Ferrari S.

Acta Oncol. 2018 Mar 13:1-7. doi: 10.1080/0284186X.2018.1449250. [Epub ahead of print]

PMID:
29533113
21.

Carnosine in health and disease.

Artioli GG, Sale C, Jones RL.

Eur J Sport Sci. 2018 Mar 4:1-10. doi: 10.1080/17461391.2018.1444096. [Epub ahead of print]

PMID:
29502490
22.

Clear Cell Sarcoma-like Tumor of the Gastrointestinal Tract: Clinical Outcome and Pathologic Features of a Molecularly Characterized Tertiary Center Case Series.

Libertini M, Thway K, Noujaim J, Puls F, Messiou C, Fisher C, Jones RL.

Anticancer Res. 2018 Mar;38(3):1479-1483.

PMID:
29491075
23.

Advances in the treatment of soft tissue sarcoma: focus on eribulin.

Koliou P, Karavasilis V, Theochari M, Pollack SM, Jones RL, Thway K.

Cancer Manag Res. 2018 Feb 1;10:207-216. doi: 10.2147/CMAR.S143019. eCollection 2018. Review.

24.

Olaratumab in soft tissue sarcoma - Current status and future perspectives.

Antoniou G, Lee ATJ, Huang PH, Jones RL.

Eur J Cancer. 2018 Mar;92:33-39. doi: 10.1016/j.ejca.2017.12.026. Epub 2018 Feb 3.

25.

Older bisexual people: Implications for social work from the 'Looking Both Ways' study.

Jones RL, Almack K, Scicluna R.

J Gerontol Soc Work. 2018 Apr;61(3):334-347. doi: 10.1080/01634372.2018.1433262. Epub 2018 Feb 5.

PMID:
29377781
26.

Delineating differential regulatory signatures of the human transcriptome in the choriodecidua and myometrium at term labor.

Lui S, Duval C, Farrokhnia F, Girard S, Harris LK, Tower CL, Stevens A, Jones RL.

Biol Reprod. 2018 Mar 1;98(3):422-436. doi: 10.1093/biolre/iox186.

PMID:
29329366
27.

Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma.

Pender A, Jones RL.

Clin Pharmacol. 2017 Dec 4;9:159-164. doi: 10.2147/CPAA.S130178. eCollection 2017. Review.

28.

Opening One's Eyes to Mosaicism in Progressive External Ophthalmoplegia.

Sommerville EW, Jones RL, Hardy SA, Blakely EL, Pyle A, Schaefer AM, Chinnery PF, Turnbull DM, Gorman GS, Taylor RW.

Neurol Genet. 2017 Dec 15;3(6):e202. doi: 10.1212/NXG.0000000000000202. eCollection 2017 Dec. No abstract available.

29.

Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma.

McGovern Y, Zhou CD, Jones RL.

Front Oncol. 2017 Nov 30;7:292. doi: 10.3389/fonc.2017.00292. eCollection 2017. Review.

30.

Clinical and Molecular Spectrum of Liposarcoma.

Lee ATJ, Thway K, Huang PH, Jones RL.

J Clin Oncol. 2018 Jan 10;36(2):151-159. doi: 10.1200/JCO.2017.74.9598. Epub 2017 Dec 8.

PMID:
29220294
31.

Biomonitoring method for the analysis of chromium and cobalt in human whole blood using inductively coupled plasma - kinetic energy discrimination - mass spectrometry (ICP-KED-MS).

Georgi JC, Sommer YL, Ward CD, Cheng PY, Jones RL, Caldwell KL.

Anal Methods. 2017;9(23):3464-3476. doi: 10.1039/C7AY00430C. Epub 2017 Apr 19.

32.

Systemic therapy in retroperitoneal sarcoma management.

Constantinidou A, Jones RL.

J Surg Oncol. 2018 Jan;117(1):87-92. doi: 10.1002/jso.24933. Epub 2017 Nov 30. Review.

PMID:
29194633
33.

Effect of Clinical Variables on the Volume of Blood Collected for Blood Cultures in an Adult Patient Population.

Jones RL, Sayles HR, Fey PD, Rupp ME.

Infect Control Hosp Epidemiol. 2017 Dec;38(12):1493-1497. doi: 10.1017/ice.2017.230. Epub 2017 Nov 21.

PMID:
29157318
34.

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.

Higham CS, Steinberg SM, Dombi E, Perry A, Helman LJ, Schuetze SM, Ludwig JA, Staddon A, Milhem MM, Rushing D, Jones RL, Livingston M, Goldman S, Moertel C, Wagner L, Janhofer D, Annunziata CM, Reinke D, Long L, Viskochil D, Baker L, Widemann BC.

Sarcoma. 2017;2017:8685638. doi: 10.1155/2017/8685638. Epub 2017 Sep 12.

35.

Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas.

Pierce DB, Johnson GE, Monroe E, Loggers ET, Jones RL, Pollack SM, Padia SA.

AJR Am J Roentgenol. 2018 Jan;210(1):175-182. doi: 10.2214/AJR.16.17573. Epub 2017 Nov 1.

PMID:
29090997
36.

Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis.

Lean SC, Derricott H, Jones RL, Heazell AEP.

PLoS One. 2017 Oct 17;12(10):e0186287. doi: 10.1371/journal.pone.0186287. eCollection 2017. Review.

37.

Surface interaction parameter measurement of solvated polymers via model end-tethered chains.

Sheridan RJ, Orski SV, Jones RL, Satija SK, Beers KL.

Macromolecules. 2017 Sep;50(17):6668-6678. doi: 10.1021/acs.macromol.7b00639. Epub 2017 Aug 16.

PMID:
28970637
38.

First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.

Pollack SM, Lu H, Gnjatic S, Somaiah N, O'Malley RB, Jones RL, Hsu FJ, Ter Meulen J.

J Immunother. 2017 Oct;40(8):302-306. doi: 10.1097/CJI.0000000000000183.

PMID:
28891906
39.

Biochemical and aerosol characterization of ricin for use in non-clinical efficacy studies.

Barnewall RE, Riffle CG, Jones RL, Guistino DJ, Chou RM, Anderson MS, Vassar ML, Howland CA.

J Biochem Mol Toxicol. 2017 Dec;31(12). doi: 10.1002/jbt.21980. Epub 2017 Sep 7.

PMID:
28881502
40.

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.

Demetri GD, Schöffski P, Grignani G, Blay JY, Maki RG, Van Tine BA, Alcindor T, Jones RL, D'Adamo DR, Guo M, Chawla S.

J Clin Oncol. 2017 Oct 20;35(30):3433-3439. doi: 10.1200/JCO.2016.71.6605. Epub 2017 Aug 30.

PMID:
28854066
41.

Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.

Jones RL, Katz D, Loggers ET, Davidson D, Rodler ET, Pollack SM.

Med Oncol. 2017 Aug 29;34(10):167. doi: 10.1007/s12032-017-1030-2.

42.

Placental Dysfunction Underlies Increased Risk of Fetal Growth Restriction and Stillbirth in Advanced Maternal Age Women.

Lean SC, Heazell AEP, Dilworth MR, Mills TA, Jones RL.

Sci Rep. 2017 Aug 29;7(1):9677. doi: 10.1038/s41598-017-09814-w.

43.

Sarcoma: Does histotype-tailored neoadjuvant therapy improve outcomes?

Jones RL, Thway K.

Nat Rev Clin Oncol. 2017 Oct;14(10):589-590. doi: 10.1038/nrclinonc.2017.118. Epub 2017 Aug 8. No abstract available.

PMID:
28786415
44.

Measurement Challenges at Low Blood Lead Levels.

Caldwell KL, Cheng PY, Jarrett JM, Makhmudov A, Vance K, Ward CD, Jones RL, Mortensen ME.

Pediatrics. 2017 Aug;140(2). pii: e20170272. doi: 10.1542/peds.2017-0272. Epub 2017 Jul 17.

45.

Desmoplastic small round cell tumor: evaluation of reverse transcription-polymerase chain reaction and fluorescence in situ hybridization as ancillary molecular diagnostic techniques.

Mohamed M, Gonzalez D, Fritchie KJ, Swansbury J, Wren D, Benson C, Jones RL, Fisher C, Thway K.

Virchows Arch. 2017 Nov;471(5):631-640. doi: 10.1007/s00428-017-2207-y. Epub 2017 Jul 26.

PMID:
28748349
46.

Olaratumab for the treatment of soft-tissue sarcoma.

Pender A, Jones RL.

Future Oncol. 2017 Oct;13(24):2151-2157. doi: 10.2217/fon-2017-0210. Epub 2017 Jul 26.

PMID:
28745071
47.

Patient understanding of liver cirrhosis and improvement using multimedia education.

Goldsworthy MA, Fateen W, Thygesen H, Aldersley MA, Rowe IA, Jones RL.

Frontline Gastroenterol. 2017 Jul;8(3):214-219. doi: 10.1136/flgastro-2016-100761. Epub 2017 Jan 19.

48.

A novel in vitro model of villitis of unknown etiology demonstrates altered placental hormone and cytokine profile.

Derricott H, Heazell AEP, Greenwood SL, Jones RL.

Am J Reprod Immunol. 2017 Nov;78(5). doi: 10.1111/aji.12725. Epub 2017 Jul 6.

PMID:
28681959
49.

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.

Tap WD, Papai Z, Van Tine BA, Attia S, Ganjoo KN, Jones RL, Schuetze S, Reed D, Chawla SP, Riedel RF, Krarup-Hansen A, Toulmonde M, Ray-Coquard I, Hohenberger P, Grignani G, Cranmer LD, Okuno S, Agulnik M, Read W, Ryan CW, Alcindor T, Del Muro XFG, Budd GT, Tawbi H, Pearce T, Kroll S, Reinke DK, Schöffski P.

Lancet Oncol. 2017 Aug;18(8):1089-1103. doi: 10.1016/S1470-2045(17)30381-9. Epub 2017 Jun 23. Erratum in: Lancet Oncol. 2018 Feb;19(2):e78.

PMID:
28651927
50.

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.

Hensley ML, Patel SR, von Mehren M, Ganjoo K, Jones RL, Staddon A, Rushing D, Milhem M, Monk B, Wang G, McCarthy S, Knoblauch RE, Parekh TV, Maki RG, Demetri GD.

Gynecol Oncol. 2017 Sep;146(3):531-537. doi: 10.1016/j.ygyno.2017.06.018. Epub 2017 Jun 24.

PMID:
28651804

Supplemental Content

Loading ...
Support Center